The ROSS FDA-50 Fixed Tank Dual Shaft Mixer is built to handle a wide range of formulations and viscosities and is ideal for processes that require meticulous control over mixing, temperature, and pressure.
ROSS FDA-50 Fixed Tank Dual Shaft Mixer |© Charles Ross & Son Company
The ROSS FDA-50 Fixed Tank Dual Shaft Mixer is a custom-design agitated pressure reactor built to handle a wide range of formulations and viscosities. It is ideal for processes that require meticulous control over mixing, temperature, and pressure and comes in a compact, portable module. The design comprises a stainless-steel type 316 dished bottom vessel and removable dished cover that can accommodate internal pressures of up to 100 psi. The mixer/reactor is equipped with two agitators and has a high-speed disperser with two 6” sawtooth blades (one fixed at the bottom and one adjustable along the shaft), driven by a 5 HP explosion-proof motor that moves up to 1760 rpm. This speed creates a vortex into which dry ingredients can be delivered for fast wetting. The disperser is belt-driven and has a removeable drive motor, belt, and guard. In addition, the two-wing anchor agitator is direct-driven by a 5 HP explosion-proof removable gearmotor that moves up to 45 rpm. The agitator is designed with a heavy-duty triangular cross-section and has removeable Teflon sidewall scrapers. The anchor feeds product toward the high-speed disperser blades, ensuring that batch contents do not stagnant in any one area. The mixer shafts use dry-running single mechanical seals that are compatible with various solvents. In addition, all product wetted surfaces are polished to a 320-grit finish. This mixer/reactor also houses a 2” flush tank discharge ball valve that leads to a sanitary outlet connection. It also contains an assortment of sanitary inlet ports on the cover. The mobile mixer remains stable on four splayed stainless-steel legs with foot pads and non-marking urethane casters, two of which lock and two of which are rigid. The casters make it easy to move the unit around.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.